Uiuce modulab

From 2013.igem.org

(Difference between revisions)
Line 349: Line 349:
       <ul class="nav navbar-nav pull-right">
       <ul class="nav navbar-nav pull-right">
       <li><a href="https://2013.igem.org/Team:UIUC_Entrepreneurs"><font size="5"><b>Home</b></font></a></li>
       <li><a href="https://2013.igem.org/Team:UIUC_Entrepreneurs"><font size="5"><b>Home</b></font></a></li>
-
     <li><a href="https://2013.igem.org/Uiuce_bus_model"><font size="5"><b>Business Model</a></li>
+
     <li><a href="https://2013.igem.org/Uiuce_bus_model"><font size="5"><b>Business Model</b></font></a></li>
-
       <li><a href="https://2013.igem.org/Uiuce_modulab">ModuLab</a></li></b></font>
+
       <li><a href="https://2013.igem.org/Uiuce_modulab"><font size="5"><b>ModuLab</b></font></a></li></b></font>
            
            
      
      

Revision as of 00:39, 29 October 2013

pic

ModuLab


Data

Overview


Modifying genomes has never been easier than it is today. No more harvesting your own restriction enzymes, DNA sequencing is outsourced, and biological parts are joining the registry by the hundreds. Synthetic biology is on the brink of becoming the next industrial revolution, but is still lacking on one major component that has catalyzed every industry in history to fame: automation. Vivosynth has conceived of the idea of a completely automated cloning machine ModuLab that can produce plasmids at a fraction of the cost at which you pay today.